Typ-1-Diabetes und kardiovaskuläre Risikofaktoren bei Kindern und Jugendlichen

Zusammenfassung

Die langfristigen kardiovaskulären Folgen des Typ-1-Diabetes determinieren die Lebenserwartung betroffener Kinder und Jugendlicher. Risikofaktoren für deren Entwicklung sind eine längere Diabetesdauer bzw. Diabetesmanifestation im frühen Lebensalter, Hypertonie, Rauchen, hoher BMI sowie Fettstoffwechselstörungen. Das Management der kardiovaskulären Risikofaktoren bei Kindern und Jugendlichen mit Typ-1-Diabetes beinhaltet zum einen Screeningsmaßnahmen zur frühzeitigen Aufdeckung der pathologischen Veränderungen und zum anderen eine Lebensstilanpassung im Sinne einer ausgewogenen, normokalorischen Ernährung, regelmäßiger Bewegung sowie ggf. einer medikamentösen lipid- bzw. blutdrucksenkenden Therapie.

Die Leitlinien und Empfehlungen zur standardisierten Erkennung und Behandlung kardiovaskulärer Risikofaktoren bei jungen Menschen mit Typ-1-Diabetes sind bisher uneinheitlich formuliert und werden deshalb nicht immer im klinischen Alltag angewendet bzw. umgesetzt. Dies führt zu einer relevanten Unterversorgung dieser Patientengruppe. Dem gilt es mit mehr Forschungsansätzen und der Entwicklung eines universellen Prozederes zur Diagnostik und Therapie der kardiovaskulären Risikofaktoren entgegenzuwirken.

Abstract

The long-term cardiovascular consequences of type 1 diabetes determine the life expectancy of affected children and adolescents. Risk factors for their development are a longer duration of diabetes or diabetes onset at an early age, hypertension, smoking, high BMI, and dyslipidemia. The management of cardiovascular risk factors in children and adolescents with type 1 diabetes includes screening measures for early detection of pathological changes on the one hand and lifestyle adjustment in terms of a balanced, normocaloric diet, regular exercise and, if necessary, lipid- or blood pressure-lowering therapy on the other hand.

The guidelines and recommendations for standardized detection and treatment of cardiovascular risk factors in young people with type 1 diabetes have so far been formulated inconsistently and are therefore not always applied or implemented in clinical practice. This results in a relevant undertreatment of this patient group. This must be counteracted with more research approaches and the development of a universal procedure for the diagnosis and treatment of cardiovascular risk factors.

Schlüsselwörter

Prävention - cIMT - Lipidstörungen

Keywords

prevention - cIMT - lipid disorders

Publication History

Received: 24 August 2021

Accepted after revision: 03 December 2021

Article published online:
07 March 2022

• Literatur

• 1 Tittel SR, Rosenbauer J, Kamrath C. et al. Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany?. Diabetes Care 2020; 43: e172-e173 DOI: 10.2337/dc20-1633. (PMID: 32826282)
• 2 Neu A, Burger-Busing J, Danne T. et al. Diagnosis Therapy and Follow Up of Diabetes Mellitus in Children and Adolescents. Exp Clin Endocrinol Diabetes 2019; 127 (Suppl. 01) 39-72 DOI: 10.1055/a-1018-8963. (PMID: 31860926)
• 3 Rawshani A, Sattar N, Franzén S. et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet 2018; 392: 477-486 DOI: 10.1016/S0140-6736(18)31506-X.
• 4 Stettler C, Allemann S, Jüni P. et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart Jl 2006; 152 (01) 27-38 DOI: 10.1016/j.ahj.2005.09.015.
• 5 Nathan DM, Genuth S, Lachin J. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329 (14) 977-986 DOI: 10.1056/NEJM199309303291401. (PMID: 8366922)
• 6 Bebu I, Schade D, Braffett B. et al. Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes Care 2020; 43 (04) 867-874 DOI: 10.2337/dc19-2292.. (PMID: 32001614)
• 7 Sherr JL, Schwandt A, Phelan H. et al. Hemoglobin A1c Patterns of Youth With Type 1 Diabetes 10 Years Post Diagnosis From 3 Continents. Pediatrics 2021; 148 (02) e2020048942 DOI: 10.1542/peds.2020-048942. (PMID: 34315809)
• 8 Clemmons DR. Involvement of insulin-like growth factor-I in the control of glucose homeostasis. Curr Opin Pharmacol 2006; 6 (06) 620-625 DOI: 10.1016/j.coph.2006.08.006.. (PMID: 17030015)
• 9 Lawson ML, Gerstein HC, Tsui E. et al. Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis. Diabetes Care 1999; 22 (Suppl. 02) B35-B39 (PMID: 10097897)
• 10 Alman AC, Talton JW, Wadwa RP. et al. Cardiovascular health in adolescents with type 1 diabetes: the SEARCH CVD study. Pediatr Diabetes 2014; 15 (07) 502-510 DOI: 10.1111/pedi.12120.. (PMID: 24450411)
• 11 Lu L, Marcovecchio ML, Dalton RN. et al. Cardiovascular autonomic dysfunction predicts increasing albumin excretion in type 1 diabetes. Pediatr Diabetes 2018; 19 (03) 464-469 DOI: 10.1111/pedi.12614.. (PMID: 29171134)
• 12 Kavey RL W, Allada V, Daniels SR. et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. J Cardiovasc Nurs; May-Jun 2007; 22 (03) 218-253 DOI: 10.1097/01.JCN.0000267827.50320.85.. (PMID: 17545824)
• 13 Sharma H, Lencioni M, Narendran P. Cardiovascular disease in type 1 diabetes. Cardiovasc Endocrinol Metab 2019; 8: 28-34 DOI: 10.1097/XCE.0000000000000167. (PMID: 31646295)
• 14 Cooper ME, Bonnet F, Oldfield M. et al. Mechanisms of diabetic vasculopathy: an overview. Am J Hypertens 2001; 14: 475-486 DOI: 10.1016/s0895-7061(00)01323-6. (PMID: 11368471)
• 15 Edge JA, James T, Shine B. Longitudinal screening of serum lipids in children and adolescents with Type 1 diabetes in a UK clinic population. Diabet Med 2008; 25 (08) 942-948 DOI: 10.1111/j.1464-5491.2008.02518.x.
• 16 Pozza RD, Bechtold S, Bonfig W. et al. Age of onset of type 1 diabetes in children and carotid intima medial thickness. J Clin Endocrinol Metab 2007; 92 (06) 2053-2057 DOI: 10.1210/jc.2006-2868. (PMID: 17374703)
• 17 de Ferranti SD, Steinberger J, Ameduri R. et al. Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association. Circulation 2019; 139 (13) e603-e634 DOI: 10.1161/CIR.0000000000000618. (PMID: 30798614)
• 18 McGill Jr HC, McMahan CA, Malcom GT. et al. Relation of glycohemoglobin and adiposity to atherosclerosis in youth: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 1995; 15 (04) 431-440 DOI: 10.1161/01.atv.15.4.431. (PMID: 7749853)
• 19 Gul K, Ustun I, Aydin Y. et al. Carotid intima-media thickness and its relations with the complications in patients with type 1 diabetes mellitus. Anadolu Kardiyol Derg 2010; 10 (01) 52-58 DOI: 10.5152/akd.2010.012. (PMID: 20150006)
• 20 Ogawa Y, Uchigata Y, Iwamoto Y. Progression factors of carotid intima media thickness and plaque in patients with long-term, early-onset type 1 diabetes mellitus in Japan: simultaneous comparison with diabetic retinopathy. J Atheroscler Thromb 2009; 16 (06) 821-828 DOI: 10.5551/jat.1701. (PMID: 19763015)
• 21 Giannopoulou EZ, Doundoulakis I, Antza C. et al. Subclinical arterial damage in children and adolescents with type 1 diabetes: A systematic review and meta-analysis. Pediatr Diabetes 2019; 20 (06) 668-677 DOI: 10.1111/pedi.12874. (PMID: 31173658)
• 22 Järvisalo MJ, Jartti L, Näntö-Salonen K. et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 2001; 104 (24) 2943-2947 DOI: 10.1161/hc4901.100522.. (PMID: 11739310)
• 23 Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol 2003; 41 (04) 661-665 DOI: 10.1016/s0735-1097(02)02894-2.. (PMID: 12598080)
• 24 Krebs A, Schmidt-Trucksäss A, Doerfer J. et al. Cardiovascular risk in pediatric type 1 diabetes: sex-specific intima-media thickening verified by automatic contour identification and analyzing systems. Pediatr Diabetes 2012; 13 (03) 251-258 DOI: 10.1111/j.1399-5448.2011.00814.x.. (PMID: 21933316)
• 25 Harrington J, Peña AS, Gent R. et al. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J Pediatr 2010; 156 (02) 237-241 DOI: 10.1016/j.jpeds.2009.08.036. (PMID: 19853860)
• 26 Schwab KO, Doerfer J, Marg W. et al. Characterization of 33 488 children and adolescents with type 1 diabetes based on the gender-specific increase of cardiovascular risk factors. Pediatr Diabetes 2010; 11 (05) 357-363 DOI: 10.1111/j.1399-5448.2010.00665.x. (PMID: 20624248)
• 27 Vergès B. Dyslipidemia in Type 1 Diabetes: A Masked Danger. Trends Endocrinol Metab 2020; 31 (06) 422-434 DOI: 10.1016/j.tem.2020.01.015. (PMID: 32217073)
• 28 Guy J, Ogden L, Wadwa P. et al. Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study. Diabetes Care 2009; 32 (03) 416-420 DOI: 10.2337/dc08-1775.
• 29 Hoogeveen RC, Gaubatz JW, Sun W. et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol 2014; 34 (05) 1069-1077 DOI: 10.1161/ATVBAHA.114.303284. (PMID: 24558110)
• 30 Koebnick C, Imperatore G, Jensen ET. et al. Progression to hypertension in youth and young adults with type 1 or type 2 diabetes: The SEARCH for Diabetes in Youth Study. J Clin Hypertens (Greenwich) 2020; 22 (05) 888-896 DOI: 10.1111/jch.13849. (PMID: 32297456)
• 31 Marcovecchio ML, Tossavainen PH, Acerini CL. et al. Maternal but not paternal association of ambulatory blood pressure with albumin excretion in young offspring wth type 1 diabetes. Diabetes Care 2010; 33 (02) 366-371 DOI: 10.2337/dc09-1152. (PMID: 19918004)
• 32 Laurent S, Cockcroft J, Van BL. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27 (21) 2588-2605 DOI: 10.1093/eurheartj/ehl254. (PMID: 17000623)
• 33 Dost A, Molz E, Krebs A. et al. Pulse pressure in children and adolescents with type 1 diabetes mellitus in Germany and Austria. Pediatr Diabetes 2014; 15 (03) 236-243 DOI: 10.1111/pedi.12083.
• 34 Donaghue KC, Marcovecchio ML, Wadwa RP. et al. ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes 2018; 19 (Suppl. 27) 262-274 DOI: 10.1111/pedi.12742. (PMID: 30276975)
• 35 Margeirsdottir HD, Larsen JR, Brunborg C. et al. High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a Population-based study. Diabetologia 2008; 51 (04) 554-561 DOI: 10.1007/s00125-007-0921-8. (PMID: 18196217)
• 36 Dost A, Bechtold S, Fink K. et al. 2017 American Academy of Pediatrics Clinical Practice Guideline: Impact on Prevalence of Arterial Hypertension in Children and Adolescents With Type 1 Diabetes. Diabetes Care 2020; 43 (06) 1311-1318 DOI: 10.2337/dc19-2022. (PMID: 32229598)
• 37 Matsushita K, Coresh J, Sang Y. et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol 2015; 3: 514-525 DOI: 10.1016/S2213-8587(15)00040-6. (PMID: 26028594)
• 38 Rawshani A, Rawshani A, Sattar N. et al. Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus. Circulation 2019; 139 (16) 1900-1912 DOI: 10.1161/CIRCULATIONAHA.118.037454. (PMID: 30798638)
• 39 Edqvist J, Rawshani A, Adiels M. et al. BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox. Diabetes Care 2019; 42 (07) 1297-1304 DOI: 10.2337/dc18-1446. (PMID: 31048408)
• 40 Kime NH, Pringle A, Rivett MJ. et al. Physical activity and exercise in adults with type 1 diabetes: understanding their needs using a person-centered approach. Health Educ Res 2018; 33 (05) 375-388 DOI: 10.1093/her/cyy028. (PMID: 30184073)
• 41 Riddel MC, Gallen IW, Smart CE. et al. Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrino 2017; 5 (05) 377-390 DOI: 10.1016/S2213-8587(17)30014-1.
• 42 Valerio G, Mozzillo E, Zito E. et al. Alcohol consumption or cigarette smoking and cardiovascular disease risk in youth with type 1 diabetes. Acta Diabetol 2019; 56 (12) 1315-1321 DOI: 10.1007/s00592-019-01415-5. (PMID: 31493030)
• 43 Hofer SE, Rosenbauer J, Gurlich-Henn J. et al. Smoking and metabolic control in adolescents with type 1 diabetes. J Pediatr 2009; 154 (01) 20-23.e1 DOI: 10.1016/j.jpeds.2008.07.052.
• 44 Schwab KO, Doerfer J, Scheidt-Nave C. et al. Algorithm-based cholesterol monitoring in children with type 1 diabetes. J Pediatr 2014; 164 (05) 1079-1084.e2 DOI: 10.1016/j.jpeds.2013.12.038.
• 45 Guy J, Ogden L, Wadwa RP. et al. Lipid and lipoprotein profiles in youth with and without type 1 diabetes. Diabetes Care 2009; 32 (03) 416-420 DOI: 10.2337/dc08-1775. (PMID: 19092167)
• 46 Packard CJ, Saito Y. Non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb 2004; 11 (01) 6-14 DOI: 10.5551/jat.11.6. (PMID: 15067193)
• 47 Frontini MG, Srinivasan SR, Xu J. et al. Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: The Bogalusa Heart Study. Pediatrics 2008; 121 (05) 924-+929 DOI: 10.1542/peds.2007-1472. (PMID: 18450895)
• 48 Touboul PJ, Hennerici MG, Meairs S. et al. Mannheim Intima-Media Thickness Consensus. Cerebrovasc Dis 2004; 8: 346-349 DOI: 10.1159/000081812. (PMID: 23128470)
• 49 Torkar AD, Plesnik E, Groselj U. et al. Carotid Intima-Media Thickness in Healthy Children and Adolescents: Normative Data and Systematic Literature Review. Front Cardiovasc Med 2020; 7: 597768 DOI: 10.3389/fcvm.2020.597768.
• 50 Danne T, Kordonouri O, Biester T. et al. Time in Range: ein neuer Parameter – komplementär zum HbA1c. Dtsch Arztebl 2019; 116 (43) DOI: 10.3238/PersDia.2019.10.25.01.
• 51 Beck RW, Bergenstal RM, Laffel LM. et al. Advances in technology for management of type 1 diabetes. Lancet 2019; 394: 1265-1273 DOI: 10.1016/S0140-6736(19)31142-0. (PMID: 31533908)
• 52 Schwab KO, Doerfer J, Hungele A. et al. Non-High-Density Lipoprotein Cholesterol in Children with Diabetes: Proposed Treatment Recommendations Based on Glycemic Control, Body Mass Index, Age, Sex, and Generally Accepted Cut Points. J Pediatr 2015; 167 (06) 1436-1439 DOI: 10.1016/j.jpeds.2015.09.006.
• 53 Mendelson MM, Regh T, Chan J. et al. Correlates of Achieving Statin Therapy Goals in Children and Adolescents with Dyslipidemia. J Pediatr 2016; 178: 149-155 DOI: 10.1016/j.jpeds.2016.08.003. (PMID: 27592099)
• 54 Nicholls SJ, Tuzcu EM, Sipahi I. et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 2007; 297 (05) 499-508 DOI: 10.1001/jama.297.5.499. (PMID: 17284700)
• 55 Luirink IK, Wiegman A, Kusters DM. et al. 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia. N Engl J Med 2019; 381 (16) 1547-1556 DOI: 10.1056/NEJMoa1816454. (PMID: 31618540)
• 56 Tell S, Nadeau KJ, Eckel RH. Lipid management for cardiovascular risk reduction in type 1 diabetes. Current Opinion in Endocrinology & Diabetes and Obesity 2020; 27 (04) 207-214 DOI: 10.1097/MED.0000000000000551.
• 57 Marcovecchio ML, Chiesa ST, Bond S. et al. AdDIT Study Group. ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes. N Engl J Med 2017; 377 (18) 1733-1745 DOI: 10.1056/NEJMoa1703518.. (PMID: 29091568)
• 58 Shah VN, Grimsmann JM, Foster NC. et al. Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow-up (Germany, Austria) registries. Diabetes Obes Metab 2020; 22 (09) 1577-1585 DOI: 10.1111/dom.14069. (PMID: 32329127)
• 59 Civeira F, Plana N. Treatment of Heterozygous Familial Hypercholesterolemia in Children and Adolescents: An Unsolved Problem. Rev Esp Cardiol (Engl Ed) 2017; 70 (06) 423-424 DOI: 10.1016/j.rec.2017.02.008. (PMID: 28284630)
• 60 Nordestgaard BG, Chapman MJ, Humphries SE. et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013; 34 (45) 3478-3490a DOI: 10.1093/eurheartj/eht273. (PMID: 23956253)
• 61 Chourdakis M, Buderus S, Dokoupil K. et al. S2k-Leitlinien zur Diagnostik und Therapie von Hyperlipidämien bei Kindern und Jugendlichen. 2015
• 62 Kordonouri O, Lange K, Boettcher I. et al. New approach for detection of LDL-hypercholesterolemia in the pediatric population: The Fr1dolin-Trial in Lower Saxony, Germany. Atherosclerosis 2019; 280: 85-91 DOI: 10.1016/j.atherosclerosis.2018.11.011. (PMID: 30496984)
• 63 Glackin S, Islam N, Henderson AM. et al. Ambulatory blood pressure and carotid intima media thickness in children with type 1 diabetes. Pediatr Diabetes 2020; 21 (02) 358-365 DOI: 10.1111/pedi.12960. (PMID: 31825119)
• 64 Faienza MF, Acquafredda A, Tesse R. et al. Risk factors for subclinical atherosclerosis in diabetic and obese children. Int J Med Sci 2013; 10 (03) 338-343 DOI: 10.7150/ijms.5181.. (PMID: 23423872)
• 65 Järvisalo MJ, Putto-Laurila A, Jartti L. et al. Carotid Artery Intima-Media Thickness in Children With Type 1 Diabetes. Diabetes 2002; 51 (02) 493-498 DOI: 10.2337/diabetes.51.2.493.. (PMID: 11812760)
• 66 Kafalidis G, Liasis N, Patsornou E. et al. Carotid intima media thickness (CIMT) of children with type 1 diabetes mellitus before and after four years. Hormone Research in Paediatrics 2012; 78 (Suppl. 01) 163-163
• 67 Rathsman B, Rosfors S, Sjöholm A. et al. Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes. Cardiovasc Diabetol 2012; 11: 145-145 DOI: 10.1186/1475-2840-11-145.. (PMID: 23185996)
• 68 Palombo C, Kozakova M, Morizzo C. et al. Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes. Cardiovasc Diabetol 2011; 10: 88 DOI: 10.1186/1475-2840-10-88.. (PMID: 21981808)
• 69 Atwa HA, Shora H. Glycemic control could reverse subclinical atherosclerotic and normal adiponectin levels in lean type-1 diabetic children. Journal of Clinical and Basic Cardiology 2011; 14 (01) 3-6
• 70 Babar GS, Zidan H, Widlansky ME. et al. Impired endothelial function in preadolscent children with type 1 diabetes. Diabetes Care 2011; 34 (03) 681-685 DOI: 10.2337/dc10-2134..
• 71 Sherif EM, Abdelmaksoud AA, Issa HM. et al. Soluble receptor for advanced glycation end products (sRAGE) and carotid intima-media thickness (CIMT) in type 1 diabetes Mellitus: Possible association with diabetic vascular complications. Pediatric Diabetes 2011; 12 (Suppl. 15) 46-47
• 72 Harrington J, Peña AS, Gent R. et al. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J Pediatr 2010; 156 (02) 237-241 DOI: 10.1016/j.jpeds.2009.08.036. (PMID: 19853860)
• 73 Rabago Rodriguez R, Gomez-Diaz RA, Tanus Haj J. et al. Carotid intimamedia thickness in pediatric type 1 diabetic patients. Diabetes Care 2007; (10) 2599-2602 DOI: 10.2337/dc07-0922.
• 74 Głowińska-Olszewska B, Tołwińska J, Urban M. et al. Relationship between endothelial dysfunction, carotid artery intima media thickness and circulating markers of vascular inflammation in obese hypertensive children and adolescents. J Pediatr Endocrinol Metab 2007; 20 (10) 1125-1136 (PMID: 18051931)
• 75 Järvisalo MJ, Raitakari M, Toikka J. et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004; 109 (14) 1750-1755 DOI: 10.1161/01.CIR.0000124725.46165.2C. (PMID: 15023875)
• 76 Dalla Pozza R, Netz H, Schwarz HP. et al. Subclinical atherosclerosis in diabetic children: results of a longitudinal study. Pediatr Diabetes 2010; 11 (02) 129-133 DOI: 10.1111/j.1399-5448.2009.00540.x.. (PMID: 19515025)